Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
828
-
Total shares
-
65.5M
-
Shares change
-
-1.78M
-
Total reported value, excl. options
-
$25.7B
-
Value change
-
-$684M
-
Put/Call ratio
-
0.97
-
Number of buys
-
357
-
Number of sells
-
-344
-
Price
-
$393.11
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q3 2020
843 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q3 2020.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 828 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.5M shares
of 80.8M outstanding shares and own 81.02% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.21M shares), Fundsmith LLP (4.23M shares), STATE STREET CORP (3.68M shares), BAMCO INC /NY/ (3.24M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.03M shares), GEODE CAPITAL MANAGEMENT, LLC (1.57M shares), BLAIR WILLIAM & CO/IL (1.51M shares), ALLIANCEBERNSTEIN L.P. (1.35M shares), AMERICAN CENTURY COMPANIES INC (1.22M shares), and PRINCIPAL FINANCIAL GROUP INC (1.19M shares).
This table shows the top 828 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.